-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Finch Therapeutics Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- Finch Therapeutics Group, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.28M, a 56.5% decline year-over-year.
- Finch Therapeutics Group, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $5.34M, a 36.5% increase year-over-year.
- Finch Therapeutics Group, Inc. annual Nonoperating Income (Expense) for 2023 was $5.65M, a 496% increase from 2022.
- Finch Therapeutics Group, Inc. annual Nonoperating Income (Expense) for 2022 was $947K, a 48.1% decline from 2021.
- Finch Therapeutics Group, Inc. annual Nonoperating Income (Expense) for 2021 was $1.83M, a 1821% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)